FDA: Omicron-specific boosters must target new strains

COVID boosters for the fall must target newer omicron types, FDA says

Pfizer and Moderna already were brewing and testing boosters updated against the first omicron mutant in anticipation of an October rollout.

FDA wants COVID boosters targeting Omicron BA.4, BA.5 subvariants

The FDA has recommended COVID-19 vaccine manufacturers change the design of their booster shots to combat the Omicron BA.4 and BA.5 subvariants of the coronavirus.

FDA Panel Endorses Updated Covid Boosters Targeting Omicron Subvariants

Updated vaccines will target both virus strains that dominated in the past and current Omicron subvariants

US FDA tells pharmas to make COVID-19 boosters targeting BA.4 and BA.5

The US Food and Drug Administration on Thursday told vaccine makers that COVID boosters for this fall and winter should include components targeting the BA.4 and BA.5 sublineages of Omicron.  

COVID boosters for the fall must target newer omicron types, FDA says

Pfizer and Moderna already were brewing and testing boosters updated against the first omicron mutant in anticipation of an October rollout.

COVID boosters for the fall must target newer omicron types, FDA says

Pfizer and Moderna already were brewing and testing boosters updated against the first omicron mutant in anticipation of an October rollout.